Back to results
US 2025/0367254 A1Published application
Apoaequorin-Containing Compositions and Method of Using Same to Treat Neuronal Inflammation
AssigneeStillwaters Bioscience Group, LLC
InventorsMark Y. Underwood, James R. Moyer, JR.
Life of this patent
Estimating the term…
Abstract
The present invention is directed to methods of preconditioning neurons to reduce neuronal inflammation in a subject. Such methods include a step of administering apoaequorin to a subject, wherein the subject's neurons are preconditioned to reduce subsequent neuronal inflammation in the subject.
Claims8
A method of preconditioning neurons to reduce neuronal inflammation resulting in reduced cell death in a subject following ischemia, comprising:
- administering apoaequorin orally in a therapeutically effective dosage to the subject wherein the therapeutically effective dosage is at least 48 mg/day of apoaequorin;
- and preconditioning the subject's neurons to reduce neuronal inflammation resulting in reduced cell death in the subject following ischemia.
Dependencies are inferred from the claim text.